WAT
48
-11
EFX
30
-8
TMO
42
-6
BXP
49
-3
MSI
72
-3
SIG
44
-3
IR
63
-3
XEL
67
2
DTE
43
5
AVGO
18
-9
MU
28
-3
SWKS
38
-2
RCL
83
-2
SBUX
37
-2
GILD
47
-8
YUM
43
-6
DG
8
-2
BDX
56
10
VRSN
53
-5
CA
22
-3
WAT
48
-11
EFX
30
-8
TMO
42
-6
BXP
49
-3
MSI
72
-3
SIG
44
-3
IR
63
-3
XEL
67
2
DTE
43
5
AVGO
18
-9
MU
28
-3
SWKS
38
-2
RCL
83
-2
SBUX
37
-2
GILD
47
-8
YUM
43
-6
DG
8
-2
BDX
56
10
VRSN
53
-5
CA
22
-3
Financhill
Back

Macrogenics 10K Form

Buy
57

MGNX
Macrogenics

Last Price:
3.51
Seasonality Move:
16.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q MGNX/Macrogenics Quarterly
2023-11-06 10Q MGNX/Macrogenics Quarterly
2023-08-09 10Q MGNX/Macrogenics Quarterly
2023-05-09 10Q MGNX/Macrogenics Quarterly
2022-11-03 10Q MGNX/Macrogenics Quarterly
2022-08-08 10Q MGNX/Macrogenics Quarterly

Receive MGNX News And Ratings

See the #1 stock for the next 7 days that we like better than MGNX

MGNX Financial Statistics

Sales & Book Value

Annual Sales: $57.19M
Cash Flow: $59.57M
Price / Cash Flow: 0
Annual Sales: $1.91
Price / Book: 1.87

Profitability

EPS (TTM): -1.58000
Net Income (TTM): $-97.62M
Gross Margin: $48.97M
Return on Equity: -77.4%
Return on Assets: -36.09%

Macrogenics Earnings Forecast

Key Macrogenics Financial Ratios

  • The Gross Profit Margin over the past 9 years for MGNX is 85.62%.
  • The Selling, General & Administrative Expenses for MGNX have been equal to 91.25% of Gross Profit Margin.
  • The Research & Development expenses have been 291.26% of Revenue.
  • The Interest Expense is -15.79% of Operating Income.
  • The Net Earning history of MGNX is -15.84% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

Macrogenics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MGNX
CUSIP: 556099
Website: macrogenics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.75
Quick Ratio: 3.53

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MGNX Technical Analysis vs Fundamental Analysis

Buy
57
Macrogenics (MGNX) is a Buy

Is Macrogenics a Buy or a Sell?

  • Macrogenics stock is rated a Buy
    The current Macrogenics [MGNX] share price is $3.57. The Score for MGNX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.